甘氨酸替换外显子位置影响常染色体显性Alport综合征肾脏生存
本研究为多中心回顾性研究,纳入97例携带COL4A3或COL4A4单致病性变异的患者,随访期间终末期肾病(ESKD)患病率为28.7%(中位年龄47.5岁)。在60例胶原域甘氨酸替换患者中,突变位于远端外显子与更差的肾脏生存及eGFR下降更显著相关,而严重突变(移码、终止获得、大片段缺失、影响剪接)未影响肾脏生存。
要点
- 常染色体显性Alport综合征(ADAS)可进展至ESKD,随访ESKD患病率28.7%。
- 甘氨酸替换位于远端外显子者肾脏生存更差,eGFR下降更显著。
- 严重突变(移码、终止获得、大片段缺失、影响剪接)未影响肾脏生存。
核心结论
- ADAS可导致ESKD,甘氨酸替换累及远端外显子对肾脏生存有负面影响,可能源于三聚化缺陷。
研究设计与样本
- 多中心回顾性研究,纳入97例携带COL4A3或COL4A4单致病性变异的患者。
主要发现
- 随访期间ESKD患病率为28.7%,中位年龄47.5岁(四分位距39.1-55.8)。
- 23例携带严重突变(移码、终止获得、大片段缺失、影响剪接),60例携带胶原域甘氨酸替换。
- 甘氨酸错义变异位于远端外显子者肾脏生存更差,eGFR下降更显著。
- 严重突变的存在未影响肾脏生存。
临床怎么用
- 对ADAS甘氨酸替换患者可依据突变外显子位置(远端 vs 近端)进行个体化随访。
- 甘氨酸替换外显子位置有望纳入未来预后评分以准确预测肾脏结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unlike X-linked or autosomal recessive Alport syndrome, no clear genotype/phenotype correlation has yet been demonstrated in patients carrying a single variant of COL4A3 or COL4A4. METHODS: We carried out a multicentre retrospective study to assess the risk factors involved in renal survival in patients presenting a single pathogenic variant on COL4A3 or COL4A4. RESULTS: A total of 97 patients presenting a single pathogenic variant of COL4A3 or COL4A4 were included. The prevalence of end-stage kidney disease (ESKD) during follow-up was 28.7% [median age 47.5 years (interquartile range 39.1-55.8). A total of 23 patients carried a 'severe' mutation (frameshift, stop gain, extensive deletion, impacting splicing) and 60 patients presented a glycine substitution in a collagenous domain. In patients with glycine missense variants, the location of the mutation in the distal exons was associated with worse renal survival with a more pronounced decline in the estimated glomerular filtration rate compared with variants in proximal exons. Conversely, the presence of a severe mutation did not impact renal survival. CONCLUSION: Our results confirm that autosomal dominant Alport syndrome (ADAS) can lead to ESKD. We demonstrated that a glycine substitution involving the distal exons had a negative impact on renal survival in ADAS patients, probably due to a trimerization defect. This could help improve personalized follow-up in ADAS patients with glycine substitution and could be integrated into a future prognostic score to accurately predict renal outcomes.
引用
- Pagniez MS, Fages V, Gatinois C, et al. Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrol Dial Transplant. 2025. PMID: 39810285. doi:10.1093/ndt/gfaf011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。